ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Shukra Pharmaceuticals Rights Issue 2023 vs Vaxfab Enterprises Rights Issue 2023

Comparison between Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023. Shukra Pharmaceuticals Rights Issue 2023 is listed on BSE while Vaxfab Enterprises Rights Issue 2023 is listed on BSE.

 Shukra Pharmaceuticals LimitedVaxfab Enterprises Limited
LogoShukra Pharmaceuticals Rights Issue 2023 LogoVaxfab Enterprises Rights Issue 2023 Logo
Listing AtBSEBSE
Terms of PaymentPartial - ₹5 on ApplicationFull Amount on Application
Entitlement6 Equity Shares for every 1 Fully Paid Equity Share held6 RIGHTS EQUITY SHARES FOR EVERY 1 FULLY PAID-UP EQUITY SHARES
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarPurva Sharegistry (India) Pvt.Ltd.Cameo Corporate Services Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Shukra Pharmaceuticals Rights Issue 2023 rights issue is ₹18.79 Crores, whereas Vaxfab Enterprises Rights Issue 2023 rights issue size is ₹12.96 Crores.

 Shukra Pharmaceuticals LimitedVaxfab Enterprises Limited
Issue Size93,94,050 shares72,00,000 shares
Issue Size (Amount)₹18.79 Crores₹12.96 Crores
Issue Price₹20 per share₹18 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Shukra Pharmaceuticals Rights Issue 2023 is Feb 02, 2023 while record date of Vaxfab Enterprises Rights Issue 2023 is Jan 03, 2023.

 Shukra Pharmaceuticals LimitedVaxfab Enterprises Limited
Record DateFeb 02, 2023Jan 03, 2023
Credit of Rights EntitlementsFeb 13, 2023Jan 13, 2023
Bid/Offer Opens OnFeb 15, 2023Jan 18, 2023
Renunciation of Rights EntitlementsFeb 23, 2023Feb 06, 2023
Bid/Offer Closes OnFeb 28, 2023Feb 10, 2023
Deemed Date of AllotmentMar 08, 2023Feb 09, 2023
Credit DateMar 14, 2023Feb 13, 2023
Listing DateMar 15, 2023Feb 16, 2023

Financials details

Comparison of Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Shukra Pharmaceuticals LimitedVaxfab Enterprises Limited
Financial
Shukra Pharmaceuticals Limited Financial Information (Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet Worth
31-Mar-2135.6111.550.1915.60
31-Mar-2235.1120.570.7516.35
Amount in ₹ Crore
Vaxfab Enterprises Limited Financial Information (Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-213.211.2-0.013.120.07
31-Mar-223.150.3703.120.02
Amount in ₹ Crore

Compare with others

Shukra Pharmaceuticals LimitedVaxfab Enterprises Limited
Bright Solar Rights Issue 2023Parvati Sweetners and Power Rights Issue 2023
Parvati Sweetners and Power Rights Issue 2023Shree Ganesh Remedies Rights Issue 2023
Shree Ganesh Remedies Rights Issue 2023Markolines Pavement Technologies Rights Issue 2023
Markolines Pavement Technologies Rights Issue 2023Hazoor Multi Projects Rights Issue 2023
Hazoor Multi Projects Rights Issue 2023Shukra Pharmaceuticals Rights Issue 2023
Vaxfab Enterprises Rights Issue 2023Aarti Surfactants Rights Issue 2023
Aarti Surfactants Rights Issue 2023Pacific Industries Rights Issue 2023
Pacific Industries Rights Issue 2023Jet Freight Logistics Rights Issue 2023
Jet Freight Logistics Rights Issue 2023Family Care Hospitals Rights Issue 2022
Family Care Hospitals Rights Issue 2022AKG EXIM Rights Issue 2022

Compare:

Shukra Pharmaceuticals Rights Issue 2023 Vs Vaxfab Enterprises Rights Issue 2023